4th Molecular Imaging & Nuclear Medicine Conference
January 28, 2010
Dubai, UAE
Once more, oncology will be marking the agenda of the Molecular Imaging & Nuclear Medicine Conference for 2010. One key area for cancer management is metabolic imaging, the backbone of MI&NM. FDG-PET has been widely used for this clinical application already.
Like the previous year, the 2010 conference will bring attendees up to date on cutting edge knowledge in MI&NM through listening to highly respected international speakers. Diagnosis, staging, restaging and response to therapy monitoring will be the key issues involved in the discussion of cancers such as breast, lung and prostate.
This activity has been approved for AMA PRA Category 1 CreditTM.
Target Audience:
- Nuclear Medicine Physicians
- Nuclear Medicine Technicians
- Oncologists
- Radiology Technicians
- Oncology Nurses
- Medical Physicists
- Paediatric Oncologists
- Radiation Oncologists
| View Conference Programme |
Attend this conference and:
- Evaluate the current status of clinical PET and molecular nuclear medicine
- Identify future challenges and directions in radiation oncology
- Discuss recent advances in the treatment of paediatric tumours
- Discuss the underlying biochemical and physical properties of 18-F-FDG and its applications to patients with various pathologies - mainly cancer
